Troy Cox

Troy Cox has joined Sophia Genetics' board of directors. Cox previously was CEO of Foundation Medicine, which was acquired by Roche last year. Prior to that he was senior vice president and an officer at Genentech. He has also held executive and senior positions with UCB BioPharmaceuticals, Sanofi-Aventis, and Schering-Plough.